CVS raises its 2025 profit forecast as turnaround plan takes effect

(Corrects paragraph 1, headline, cross-head and ⁠paragraph 9 to ⁠remove erroneous ‍reference to CVS 2026 profit outlook being above Wall Street estimates, corrects to 2026 revenue outlook to 'at least' $400 billion, instead of erroneous 'up to' $400 billion)

By Sneha S K and ‍Amina Niasse

Dec 9 (Reuters) - CVS Health raised its 2025 profit forecast on Tuesday, signalling ​steady progress in the health conglomerate's turnaround plan.

The company has delivered on its promises this year and will now focus ​on improving consumer experiences across the business, Chief Executive David Joyner said during the CVS investor day.

"We've invested heavily in what I would believe is the challenge in the marketplace, which is a lack of trust," he added.

CVS ​also announced the launch of a consumer app that is meant to increase and integrate its services, potentially driving new sources of revenue for its partners.

Shares in CVS, which operates one ​of the largest U.S. pharmacy chains, rose 4.8% to $80.17 in morning trading after the company also raised its 2025 profit outlook for ‌the fourth time.

The upbeat outlook caps a year in which Joyner pushed through a sweeping overhaul, including cost-cutting measures and withdrawals from underperforming markets while ​strengthening management to revive investor confidence. The shares have ⁠responded with gains of more than 70% this year.

"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong ‌earnings growth in 2026," Chief Financial Officer Brian Newman said on Tuesday.

The company forecast 2026 adjusted profit in the range of $7.00 to $7.20 per share, compared with analyst expectations of $7.16, according to data compiled by LSEG.

2026 REVENUE ‌OUTLOOK LAGS EXPECTATIONS

Total 2026 revenue will be at least $400 billion next year, the company forecast, below the $419.26 billion expected ‌by analysts.

The company expects growth to be powered by a return to target margins at its Aetna insurance business as well as the CVS Caremark pharmacy benefit management unit.

CVS said in May that it plans to exit ‍the market for Obamacare health insurance plans in 2026. Health insurers have struggled with increasing medical costs in these plans in recent quarters.

The company raised ⁠its 2025 adjusted profit forecast to between $6.60 and $6.70 per share, up from the previous projection of $6.55 to $6.65.

"CVS' near-term momentum should set the stage for what remains a robust growth recovery story," Leerink Partners analysts said in a note.

(Reporting by Sneha S K in Bengaluru and Amina Niasse in New York CityEditing by Shinjini Ganguli, David Goodman and Louise Heavens)

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• BofA sees mixed signals for European software from US SaaS
• Marvell (MRVL) Stock: Risk/Reward Skewed to the Upside Near-Term Following Selloff, Says Analyst